Ritonavir is a protease inhibitor used as a pharmacokinetic enhancer for other antiviral drugs in HIV therapy.
Ritonavir belongs to a class of medicines known as protease inhibitors. These agents stop a virus from making new copies of itself, helping the body control the infection. Ritonavir is most widely recognized as part of the combination product Kaletra, which pairs it with another protease inhibitor to treat viral illnesses.
The best-known product that includes ritonavir in Hong Kong is Kaletra (lopinavir/ritonavir). Kaletra is available in tablet form and as an oral solution for those who have difficulty swallowing pills. The tablets usually come in 100 mg/200 mg (lopinavir/ritonavir) strengths, while the oral solution delivers the same doses in a liquid format. In Hong Kong, both generic versions and the brand-named product are listed on the Department of Health’s registry, so patients may encounter either label when they receive a prescription.
Ritonavir is used primarily as part of combination therapy for viral infections that affect the immune system. The most common conditions include:
Because ritonavir works by blocking a key step in viral replication, it is effective for any virus that relies on protease enzymes, which is why it appears in combination products rather than as a stand-alone therapy for most patients.
Ritonavir attaches to the viral protease enzyme, preventing the virus from cutting large protein pieces into the smaller components it needs to assemble new viral particles. By halting this process, the medication reduces the spread of the virus inside the body. The effect can be seen within a few days of starting therapy, though full benefits develop over weeks as the immune system recovers.
These reactions are usually temporary and may lessen as the body adjusts to the medication.
If any of these signs appear, seek immediate medical help.
Ritonavir can affect how other medicines work. Notable interaction groups include:
Because Kaletra contains two active ingredients, each medication may have its own interaction profile. For a full list, refer to the specific product information sheet.
Store Kaletra tablets in a cool, dry place away from direct sunlight. The oral solution should be kept at room temperature and shaken gently before each use. Treatment length can vary: short courses are common for acute infections, while longer use may be required for chronic viral conditions. Always follow the instructions that come with your specific medication, as strengths and dosing schedules differ between products.
Protease inhibitor: A drug that blocks an enzyme viruses need to multiply. Viral load: The amount of virus present in the blood. Adverse reaction: An unwanted effect that occurs after taking a medicine.
This article offers general educational information about ritonavir as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing ritonavir may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.
